| 99593-6 |
American Academy of Family Physicians Social Needs Screening Tool |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
American Academy of Family Physicians Social Needs Screening Tool |
|
PANEL |
DefinitionDescription |
|
|
|
|
�©2018 American Academy of Family Physicians Used with permission. |
|
|
|
|
PANEL.SURVEY.SDOH |
|
99593-6 |
|
|
|
|
Order |
|
|
|
0 |
|
|
|
|
N |
|
AAFP Social Needs; Asympt; Asymptomatic; Pan; Panel; Panl; Pnl; Point in time; Random; Scn; Survey |
2.79 |
2.72 |
|
Panel |
|
|
�©2018 American Academy of Family Physicians Used with permission. |
|
|
|
|
|
|
0 |
| 99594-4 |
Delayed medical care due to distance or lack of transportation |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Delayed medical care due to distance or lack of transportation |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.SDOH |
|
99594-4 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Delay med care b/c distance/transport; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99595-1 |
American Academy of Family Physicians Social Needs Screening Tool - short form |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
American Academy of Family Physicians Social Needs Screening Tool - short form |
|
PANEL |
DefinitionDescription |
|
|
|
|
�©2018 American Academy of Family Physicians Used with permission. |
|
|
|
|
PANEL.SURVEY.SDOH |
|
99595-1 |
|
|
|
|
Order |
|
|
|
0 |
|
|
|
|
N |
|
AAFP Social Needs; AAFP Social Needs - short form; Asympt; Asymptomatic; Pan; Panel; Panl; Pnl; Point in time; Random; Scn; Survey |
2.79 |
2.72 |
|
Panel |
|
|
�©2018 American Academy of Family Physicians Used with permission. |
|
|
|
|
|
|
0 |
| 99596-9 |
SARS coronavirus 2 nucleocapsid protein Ab.IgG |
PrThr |
Ser/Plas |
Pt |
Ord |
IA |
|
ACTIVE |
SARS-CoV-2 (COVID-19) N protein IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
99596-9 |
|
IA |
|
|
Both |
|
|
|
0 |
SARS-CoV-2 N IgG SerPl Ql IA |
|
|
|
N |
|
2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; PH; Pl; Plasma; Plsm; Point in time; PR; Prot; Public Health; PublicHealth; Ql; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 N; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; Severe Acute Respiratory Syndrome; SR; SUDS; Viral Pneumonias; Wuhan coronavirus |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99597-7 |
SARS coronavirus 2 spike protein Ab.IgG |
PrThr |
Ser/Plas |
Pt |
Ord |
IA |
|
ACTIVE |
SARS-CoV-2 (COVID-19) S protein IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
99597-7 |
|
IA |
|
|
Both |
|
|
|
0 |
SARS-CoV-2 S IgG SerPl Ql IA |
|
|
|
N |
|
2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; PH; Pl; Plasma; Plsm; Point in time; PR; Prot; Public Health; PublicHealth; Ql; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 S; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; Severe Acute Respiratory Syndrome; SR; SUDS; Viral Pneumonias; Wuhan coronavirus |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99598-5 |
Erythrocytes.dysmorphic/Erythrocytes |
NFr |
Urine |
Pt |
Qn |
Automated count |
|
ACTIVE |
Erythrocytes.dysmorphic/Erythrocytes in Urine by Automated count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
UA |
|
99598-5 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Dysmorphic RBC/RBC NFr Ur Auto |
|
|
|
N |
|
Auto; Automated detection; D Cells; DE; Discocytes; Dysmorphic RBC; Elec; Elect; Electr; Erthrocyte; Erythrocyte; Glomerular erythrocytes; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; UA; UR; URINALYSIS; Urn |
2.79 |
2.72 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 99599-3 |
Protein.monoclonal band 1/Protein.total |
MFr |
Urine |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Protein.monoclonal band 1/Protein.total in Urine by Electrophoresis |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
99599-3 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
M Protein 1 MFr Ur Elph |
|
|
|
N |
|
Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; i; M Protein; M Protein 1; Mass Fraction; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Para protein; Paraprotein; Percent; PEUR; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; TP; UA; UPEP; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 996-9 |
D little o super little a Ag |
PrThr |
RBC |
Pt |
Ord |
|
|
ACTIVE |
Do sup(a) Ag [Presence] on Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
996-9 |
|
|
|
|
Both |
|
|
|
0 |
Do sup(a) Ag RBC Ql |
|
|
|
|
|
Antigen; Antigens; BLOOD BANK; D (little o) (little a); Dextro; Do sup(a); Do^a; Dombrock; Dombrock Blood Group System; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 9960-6 |
QRS duration.lead V6 |
Time |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
QRS duration in lead V6 |
|
MIN |
DefinitionDescription |
|
|
ms |
|
|
|
|
|
|
EKG.MEAS |
|
9960-6 |
|
EKG |
|
|
Observation |
|
|
|
0 |
QRS dur L-V6 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; QRS dur L-V6; Quan; Quant; Quantitative; Random |
2.48 |
1.0i |
|
|
|
|
|
|
|
ms |
|
|
|
0 |
| 99600-9 |
Beta 1 globulin |
MCnc |
Urine |
24H |
Qn |
Electrophoresis |
|
ACTIVE |
Beta 1 globulin [Mass/volume] in 24 hour Urine by Electrophoresis |
|
ADD |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
99600-9 |
|
Electrophoresis |
|
|
Both |
|
|
|
0 |
Beta1 Glob 24h Ur Elph-mCnc |
|
|
|
N |
|
1 day; 24 hours; 24HR; B; B1 globulin; Beta1 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; i; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 99601-7 |
Beta 2 globulin |
MCnc |
Urine |
24H |
Qn |
Electrophoresis |
|
ACTIVE |
Beta 2 globulin [Mass/volume] in 24 hour Urine by Electrophoresis |
|
ADD |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
99601-7 |
|
Electrophoresis |
|
|
Both |
|
|
|
0 |
Beta2 Glob 24h Ur Elph-mCnc |
|
|
|
N |
|
1 day; 24 hours; 24HR; B; B2 globulin; Beta2 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 99602-5 |
Glucose/Creatinine |
SRto |
Urine |
24H |
Qn |
|
|
ACTIVE |
Glucose/Creatinine [Molar ratio] in 24 hour Urine |
|
ADD |
DefinitionDescription |
|
|
mmol/mol{creat} |
|
|
|
|
|
|
CHEM |
|
99602-5 |
|
|
|
|
Both |
|
|
|
0 |
Glucose/Creat 24h Ur-sRto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Glu; Gluc; Glucoseur; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
mmol/mol{creat} |
|
|
|
0 |
| 99603-3 |
Neutrophils.band form/Leukocytes |
NFr |
Periton fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Band form neutrophils/Leukocytes in Peritoneal fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
99603-3 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Neuts Band NFr Prt Manual |
|
|
|
N |
|
Ascites; Ascitic fluid; Ascitis; Bands; bnd; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number Fraction; Percent; Peritoneal fluid; PMN; PNM; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.79 |
2.72 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 99604-1 |
Neutrophils.band form/Leukocytes |
NFr |
Plr fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Band form neutrophils/Leukocytes in Pleural fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
99604-1 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Neuts Band NFr Plr Manual |
|
|
|
N |
|
Bands; bnd; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number Fraction; Percent; Pleural; Pleural fluid; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells |
2.79 |
2.72 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 99605-8 |
Multisection for venous mapping |
Find |
Lower extremity.left>Lower extremity vein |
Pt |
Doc |
US.doppler |
|
ACTIVE |
US.doppler Lower extremity vein - left for venous mapping |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
99605-8 |
|
US.doppler |
|
|
Both |
|
|
|
0 |
DOP LE v-L for venous map |
|
|
|
N |
|
Document; DOP; DUPLEX; Echography; EXT; Extr v; Extr-L; Finding; Findings; Imaging; L; LE; LE v; LE v-L; Leg; LE-L; LLE; Low; LT; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ven; Venous |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99606-6 |
Multisection for venous mapping |
Find |
Lower extremity.right>Lower extremity vein |
Pt |
Doc |
US.doppler |
|
ACTIVE |
US.doppler Lower extremity vein - right for venous mapping |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
99606-6 |
|
US.doppler |
|
|
Both |
|
|
|
0 |
DOP LE v-R for venous map |
|
|
|
N |
|
Document; DOP; DUPLEX; Echography; EXT; Extr v; Extr-R; Finding; Findings; Imaging; LE; LE v; LE v-R; Leg; LE-R; Low; Point in time; R; Radiology; Random; RLE; RT; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ven; Venous |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99607-4 |
Multisection for venous mapping |
Find |
Lower extremity.bilateral>Lower extremity vein |
Pt |
Doc |
US.doppler |
|
ACTIVE |
US.doppler Lower extremity vein - bilateral for venous mapping |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
99607-4 |
|
US.doppler |
|
|
Both |
|
|
|
0 |
DOP LE v-Bl for venous map |
|
|
|
N |
|
Bil; Bilat; Both; Document; DOP; DUPLEX; Echography; EXT; Extr v; Extr-Bl; Finding; Findings; Imaging; LE; LE v; LE v-Bl; LE-Bl; Leg; Low; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ven; Venous |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99608-2 |
Multisection^WO & W contrast IV |
Find |
Chest>Subclavian vessels.bilateral |
Pt |
Doc |
MR.angio |
|
ACTIVE |
MRA Subclavian vessels - bilateral WO and W contrast IV |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
99608-2 |
|
MR.angio |
|
|
Both |
|
|
|
0 |
MRA Subclavian ves-Bl WO+W contr IV |
|
|
|
N |
|
Ang; Angio; Angiography; Bil; Bilat; Both; c; Contr; Contra; Contrst; Document; Finding; Findings; Imaging; Magnetic Resonance Angiographies; Magnetic resonance imaging; Mitral regurgitation maximum velocity; MR angiography; MRA; MRI; MRI.angio; Point in time; Radiology; Random; Subclavian ves-Bl; Thorax; Vesl; Vessels.XXX; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99609-0 |
Multisection^W contrast IV |
Find |
Chest>Aorta.thoracic |
Pt |
Doc |
MR.angio |
|
ACTIVE |
MRA Thoracic Aorta W contrast IV |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
99609-0 |
|
MR.angio |
|
|
Both |
|
|
|
0 |
MRA TA W contr IV |
|
|
|
N |
|
Ang; Angio; Angiography; AO; Aortic; c; Contr; Contra; Contrst; Document; Finding; Findings; Imaging; Magnetic Resonance Angiographies; Magnetic resonance imaging; Mitral regurgitation maximum velocity; MR angiography; MRA; MRI; MRI.angio; Point in time; Radiology; Random; Thorax; W contr IV; WC |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 9961-4 |
QRS initial amplitude.lead AVF |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
QRS initial amplitude in lead AVF |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9961-4 |
|
EKG |
|
|
Observation |
|
|
|
0 |
QRS I-Amp L-AVF |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; QRS I-Amp L-AVF; Quan; Quant; Quantitative; Random; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 99610-8 |
Multisection^W contrast PO |
Find |
Abdomen+Pelvis |
Pt |
Doc |
CT |
|
ACTIVE |
CT Abdomen and Pelvis W contrast PO |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
99610-8 |
|
CT |
|
|
Both |
|
|
|
0 |
CT Abd+Pelvis W contr PO |
|
|
|
N |
|
Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Pelvic; Point in time; Radiology; Random; W contr PO; WC |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99611-6 |
Multisection^WO contrast |
Find |
Abdomen>Abdominal vessels & Pelvis>Pelvis vessels |
Pt |
Doc |
MR.angio |
|
ACTIVE |
MRA Abdominal vessels and Pelvis vessels WO contrast |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
99611-6 |
|
MR.angio |
|
|
Both |
|
|
|
0 |
MRA Abd ves+Pelvis ves WO contr |
|
|
|
N |
|
Abd; Abd ves; Abd ves+Pelvis ves; Abdo; Abdomen; Abdomen+; Abdominal; Ang; Angio; Angiography; c; Contr; Contra; Contrst; Document; Finding; Findings; Imaging; Magnetic Resonance Angiographies; Magnetic resonance imaging; Mitral regurgitation maximum velocity; MR angiography; MRA; MRI; MRI.angio; Pelvic; Point in time; Radiology; Random; Vesl; Vessels.XXX; without contrast |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99612-4 |
Multisection^WO contrast |
Find |
Chest>Heart |
Pt |
Doc |
CT |
|
ACTIVE |
CT Heart WO contrast |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
99612-4 |
|
CT |
|
|
Both |
|
|
|
0 |
CT Hrt WO contr |
|
|
|
N |
|
c; Cardiac; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Hrt; Imaging; Point in time; Radiology; Random; Thorax; without contrast |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99613-2 |
Multisection^WO & W contrast IV |
Find |
Chest>Heart |
Pt |
Doc |
CT |
|
ACTIVE |
CT Heart WO and W contrast IV |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
99613-2 |
|
CT |
|
|
Both |
|
|
|
0 |
CT Hrt WO+W contr IV |
|
|
|
N |
|
c; Cardiac; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Hrt; Imaging; Point in time; Radiology; Random; Thorax; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99614-0 |
Emicizumab |
MCnc |
PPP |
Pt |
Qn |
Coag |
|
ACTIVE |
Emicizumab [Mass/volume] in Platelet poor plasma by Coagulation assay |
|
ADD |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99614-0 |
|
Coag |
|
|
Both |
|
|
|
0 |
Emicizumab PPP-mCnc |
|
|
|
N |
|
ACE910; ACE-910; Clot; Clottable; Coagulation assay; DRUG/TOXICOLOGY; Drugs; emicizumab-kxwh; GTPL9744; Level; Mass concentration; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; RG6013; Tilt tube |
2.72 |
2.72 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
